What is it about?

Despite the clinical significance of plasma copeptin in polyuria-polydipsia syndrome, there are no guidelines recommending the analytical performance specifications (APS) for this measurand. We explored the derivation of several possible APS for copeptin using different levels of evidence, as recommended by the Milan Consensus.

Featured Image

Read the Original

This page is a summary of: Setting analytical performance specifications for copeptin-based testing, Clinical Chemistry and Laboratory Medicine (CCLM), June 2024, De Gruyter,
DOI: 10.1515/cclm-2024-0626.
You can read the full text:

Read

Contributors

The following have contributed to this page